Please assess the completion status of the following clinical trial:

Trial Title: Dolutegravir in Real Life in Lesotho

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV-1-positive~* Initiating or eligible to initiate (offered to initiate) a DTG-based ART regimen~* Informed written consent (and assent, if applicable) provided~Exclusion Criteria:~* None

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- HIV-1-positive individuals (Type: None): HIV-1-positive individuals eligible to receive a DTG-based ART regimen at enrolment.

Based on this trial design, predict the completion outcome and termination type (if applicable).